He received his PhD in Chemical Engineering, from Oklahoma State University, Stillwater, OK in 1999 and subsequently was an American Heart Association postdoctoral fellow at the Lerner Research Institute of the Cleveland Clinic (1999-2001), where he developed novel, glycosaminoglycan (GAG)-based biomaterials for biomimetic tissue engineering of aortic heart valve replacements.